Home/Filings/4/0001125345-24-000055
4//SEC Filing

Spitznagel Thomas 4

Accession 0001125345-24-000055

CIK 0001125345other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:19 PM ET

Size

8.3 KB

Accession

0001125345-24-000055

Insider Transaction Report

Form 4
Period: 2024-03-04
Spitznagel Thomas
Sr VP, Technical Ops
Transactions
  • Exercise/Conversion

    Employee stock option (right to buy)

    2024-03-0410,00077,000 total
    Exercise: $11.50Exp: 2030-02-20Common Stock (10,000 underlying)
  • Sale

    Common Stock

    2024-03-04$20.00/sh10,000$200,0008,316 total
  • Exercise/Conversion

    Common Stock

    2024-03-04$11.50/sh+10,000$115,00018,316 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/17/2023.
  • [F2]12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

Issuer

MACROGENICS INC

CIK 0001125345

Entity typeother

Related Parties

1
  • filerCIK 0001675464

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:19 PM ET
Size
8.3 KB